MAKRIDES ANDREW 4
4 · Apyx Medical Corp · Filed Jul 11, 2022
Insider Transaction Report
Form 4
MAKRIDES ANDREW
DirectorCEO
Transactions
- Exercise/Conversion
Stock Option (Option to Buy)
2022-07-05−30,000→ 0 totalExercise: $2.54From: 2013-07-12Exp: 2022-07-12→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2022-07-05$2.54/sh+30,000$76,200→ 637,972 total - Tax Payment
Common Stock
2022-07-05$6.14/sh−13,583$83,400→ 624,389 total
Footnotes (2)
- [F1]Represents a "net exercise" of outstanding stock options.
- [F2]Reporting Person was granted a stock option that vested and became exercisable over 5 years at a rate of 20% of the option on the anniversary date of each year.